Finance

Beta
Lists
NGNE:NASDAQ
Neurogene Inc
$30.60
+1.76%
(+0.53) 1D
Jun 25, 2:08:02 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for NGNE...
Open
$30.07
High
$32.00
Low
$29.66
Mkt. cap
483.54M
Avg. vol.
149.50K
Volume
86.83K
52-wk high
$37.27
52-wk low
$14.65
EPS
-$4.54
Beta
1.69
Shares outstanding
15.80M
No. of employees
131
Open
$30.07
High
$32.00
Low
$29.66
Mkt. cap
483.54M
Avg. vol.
149.50K
Volume
86.83K
52-wk high
$37.27
52-wk low
$14.65
EPS
-$4.54
Beta
1.69
Shares outstanding
15.80M
No. of employees
131
News stories
From sources across the web
About Neurogene Inc
CEOJonathan Drachman M.D.
Employees131
Founded2018
Headquarters-
SectorBiotechnology
Websiteneurogene.com
Analyst Ratings
Based on 9 analysts giving stock ratings to NGNE in the past 3 months
Strong Buy
Buy
9
Hold
0
Sell
0
12 month forecast
Based on 9 Wall Street analysts offering 12 month price targets for NGNE in the last 3 months.
Highest
Current $30.60
$180.00 (+488.24%)
Average
$80.00 (+161.44%)
Lowest
$46.00 (+50.33%)
Analyst
Recommendation
Action
Price Target
Projected
Date
Patrick Dolezal
LifeSci Capital
Buy
Maintained
$60.00
+96.1%
06/22/2026
Mitchell Kapoor
H.C. Wainwright
Buy
Reiterated
$70.00
+128.8%
06/09/2026
Debjit Chattopadhyay
Guggenheim
Buy
Initiated
$69.00
+125.5%
06/09/2026
Sami Corwin
William Blair
Buy
Maintained
-
-
06/08/2026
Seema Sheoran
Rodman & Renshaw
Buy
Initiated
$70.00
+128.8%
06/03/2026
Albert Lowe
Craig-Hallum
Buy
Maintained
$65.00
+112.4%
05/15/2026
Whitney Ijem
Canaccord Genuity
Buy
Maintained
$180.00
+488.2%
05/12/2026
Ritu Baral
TD Cowen
Buy
Maintained
-
-
05/13/2026
Paul Matteis
Stifel Nicolaus
Buy
Reiterated
$46.00
+50.3%
05/13/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
19.37M
17.24M
20.52M
25.15M
Cost of revenue
19.37M
17.24M
20.52M
25.15M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
6.72M
6.56M
6.89M
8.20M
Operating expense
6.72M
6.56M
6.89M
8.20M
Total operating expenses
26.08M
23.80M
27.41M
33.35M
Operating income
-26.08M
-23.80M
-27.41M
-33.35M
Other non operating income
1.14M
107.00K
122.00K
154.00K
EBT including unusual items
-22.02M
-20.95M
-24.74M
-30.93M
EBT excluding unusual items
-22.02M
-20.95M
-24.62M
-30.93M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-22.02M
-20.95M
-24.74M
-30.93M
Net profit margin
-
-
-
-
Earnings per share
-1.05
-0.99
-1.13
-1.39
Interest and investment income
2.93M
2.74M
2.67M
2.26M
Interest expense
-1.00K
-1.00K
-1.00K
-
Net interest expenses
2.93M
2.74M
2.67M
2.26M
Depreciation and amortization charges
-
-
-
-
EBITDA
-25.31M
-23.02M
-26.62M
-32.50M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer